An early step of migrant radicalism: Far right parties and terror nexus in Europe
Is this your thesis?
This record came from a bulk archive import. If it’s yours, link it to your profile.
Abstract (EN)
This study investigates how proliferation of far right parties' policies affect increasing migrant – based terrorist incidents in Europe especially since 2011. The study aims to demonstrate what extent political, economic and social discrimination which are stemmed from European far right parties, led migrants to fall into terrorism trap. The study analyzes tendency to crime and aversion level among migrants in order to provide a perspective about whether migrants who are exposed to discrimination express themselves through violence or not with qualitative and quantitative research methods. Findings of the research shed light on how European citizens and far right parties might deal with the rising polarization within their countries. Correspondingly, European governments might prevent migrant based terrorism in Europe or at least might reduce the number of terrorist incidents via the factors as presented in this research.
Author
Edanur Önel
Institution
How to Cite
Edanur Önel (Master Thesis). An early step of migrant radicalism: Far right parties and terror nexus in Europe, 2019, Yeditepe University.
Keywords
License
Tüm Hakları Saklıdır
This work is shared under the specified license terms.
More theses from Yeditepe University
- Studies on cyclodextrin complexation of a poorly water soluble anti-hyperlipidemic drug, tablet formulation and characterization(2021)
- Washington ambassadors in Turkish-US relations (1927-1960)(2023)
- Metamorphosis of female voices: A study of the violation of women in Greek and Roman mythology and feminist rewritings reclaiming the narrative(2022)
- Knowledge distillation with foundation models for image segmentation(2023)
- The relationship between machiavelism, grandiose and vulnerable narcissism, and loneliness among white collar workers(2023)
- Evaluation of drug-drug interaction checkers along clinically relevant adverse drug events in oncology and hematology pediatric patients(2023)